All posts by imreal

Women’s Dermatologic Society Announces Leadership Transition


Women's Dermatologic Society Logo

Molly epitomizes the spirit of WDS: she is a sought-after mentor, a local and national leader, and an excellent physician.

The Women’s Dermatologic Society (WDS) announced that Marta I. Rendon, MD stepped down as the 2019-2020 President-Elect due to health concerns. The WDS Board of Directors appointed Molly Hinshaw, MD to fill the remainder of Dr. Rendon’s term.

In becoming President-Elect, Dr. Hinshaw will complete the current March 2019-March 2020 term and will be presented to the membership as the 2020-2021 President at the WDS Annual Meeting Luncheon in Denver, CO on March 22, 2020.

“We greatly appreciate the contributions Dr. Marta Rendon has made to the Women’s Dermatologic Society and thank her for dedication and years of service to the society,” said Barbara Mathes, MD, President of the Women’s Dermatologic Society.

Per WDS governing documents, the Nominating Committee met and recommended Molly Hinshaw, MD to the WDS Board of Directors to fulfill the remainder of Dr. Rendon’s term. The Board approved the recommendation on October 22, 2019.

“We welcome Dr. Molly Hinshaw to this position. She is well-prepared to be President-Elect and WDS President. Molly epitomizes the spirit of WDS: she is a sought-after mentor, a local and national leader, and an excellent physician. I, along with the WDS Board and staff, look forward to working with Dr. Hinshaw and will support her in the transition,” Dr. Mathes commented.

“This organization has taught me first-hand how we live our vision and mission through our programs. I am excited for the opportunity to lead with the exceptional Executive Committee, Board of Directors, and all committees in order to serve WDS members and the Dermatology community at large,” said Molly Hinshaw, MD, President-Elect.

About Molly Hinshaw, MD

Molly Hinshaw, MD, is dual board certified in Dermatology and Dermatopathology and is an Associate Professor of Dermatology and Section Chief of Dermatopathology at the University of Wisconsin Madison School of Medicine and Public Health.

Since joining WDS in 2002, Dr. Hinshaw has served in multiple leadership positions as a Board Member, Council Chair, and in various committee roles. She received the 2011 WDS Career & Community Advancement Award for her achievements in specialty training for diseases and disorders of the nail unit.

Dr. Hinshaw is a member of the University of Wisconsin Hospital and Clinics (UWHC) medical board, Past President of the Wisconsin Dermatological Society, and has chaired numerous committees for the American Academy of Dermatology and the American Society of Dermatopathology, as well as WDS.

During her career, she has created courses, workshops and lectures for dermatologists, dermatopathologists, dermatology residents, primary care physicians, and medical students. Her clinical expertise includes melanoma and non-melanoma skin cancer as well as disorders of the nail.

About the Women’s Dermatologic Society (WDS)

The Women’s Dermatologic Society, founded in 1973, is dedicated to helping dermatologists fulfill their greatest potential and assisting them in making a contribution to the dermatology specialty and society. To achieve this goal, the Society relies on the active participation of its members, who represent a diverse cross-section of professional sub-specialties. The organization provides unique personal and professional development opportunities to dermatologists, including networking, mentorship, education, leadership development, patient care and community service.

Share article on social media or email:

Pennsylvania College of Health Sciences Posts 94.73% Average NCLEX Pass Rate


“As the health care industry, specifically the nursing field, continues to grow and evolve, we are growing and evolving as well,” said Executive Vice President of Academic and Student Affairs Dr. Kimberly Johnston.

Pennsylvania College of Health Sciences, the area’s preeminent institution for the health care field, is pleased to announce that after the fourth quarter of the 2018-2019 academic year, the school’s NCLEX scores continue to stay above the 90th percentile with a 94.73% average pass rate. The College’s annual pass rate for the 2018-2019 academic year was 95.02%, maintaining the College’s rank above the national average of 88%.

“Our first-time pass rate continues to exceed the national average and demonstrates the high caliber of our dedicated students and faculty,” said Pennsylvania College of Health Sciences Dean of Nursing Dr. Cheryl Grab. “The consistency of NCLEX scores across the board this year exemplifies our mission as a whole — to educate for excellence in health care practice, leadership and the continuous acquisition of knowledge.”     

The College continues to make advancements to the program to ensure students are well prepared for the health field. Recent initiatives include decreasing class sizes, enhancing simulation learning experiences, incorporating Assessment Technologies Institute (ATI) learning systems into the curriculum, improving the faculty hiring and orientation process, and identifying high-risk students early on to provide them with additional assistance.

“As the health care industry, specifically the nursing field, continues to grow and evolve, we are growing and evolving as well,” said Executive Vice President of Academic and Student Affairs Dr. Kimberly Johnston. “The demand for qualified and talented registered nurses is at an all-time high. We are doing our best to educate our students to enter the workforce successfully as compassionate, well-rounded individuals and leaders.”

In addition to its established Associate Degree in Nursing program, Pennsylvania College of Health Sciences is the only institution in the region that offers an accelerated Bachelor of Science in Nursing program. The College’s rigorous curriculum prepares students for a myriad of health care settings, immersing them in a unique theoretical learning environment where collaboration between disciplines mimics that of a hospital and fosters a holistic understanding of how each professional and department works together to achieve optimal patient outcomes.

To learn more about Pennsylvania College of Health Sciences, visit http://www.PAcollege.edu.

About Pennsylvania College of Health Sciences

A dynamic and academically rigorous institution, Pennsylvania College of Health Sciences is a private, accredited, four-year college focusing exclusively on the field of health care. Offering associate, bachelor’s, master’s and doctoral degree programs, as well as a number of certificate programs, PA College provides professional development for health care workers throughout their career. Located in Lancaster, Pennsylvania, the College attracts a select group of more than 1,800 students to study with faculty who are experts in their specialty areas.

Share article on social media or email:

Motili Announces the Appointment of New CEO


News Image

Motili, a leading real estate technology solutions company, has announced that it has appointed Karl Pomeroy as its new Chief Executive Officer.

Mr. Pomeroy brings more than 30 years in HVAC sales and management to the helm at Motili. He has previously held the position of division president at Goodman Manufacturing, Motili’s parent company, where he was responsible for managing 66 locations in the Western United States. In 2017, Mr. Pomeroy became executive sponsor for Motili, responsible for corporate integration and sales leadership for the company.

Motili has been leading the way with its contractor network spanning the United States, connecting single-family, multi-family, and commercial property owners and operators to HVAC contractors, providing one point of contact for HVAC and appliance upgrades and maintenance, coast to coast.

“Today, HVAC is in the midst of revolutionary maturation where tech is making it easier than ever to optimize service levels. Motili is at the forefront of developing and implementing technology that connects with our customers, which, in turn, makes their residents happier, more comfortable, and results in energy efficient buildings that are creating ROI,” said Karl Pomeroy, CEO of Motili. “I am so happy to be working with this great group of people. Motili has an amazingly talented staff, and I have the unique pleasure of working with some of the best and the brightest people here, who are poised to bring our technology to the next level.”

Motili brings contractors, operations teams, and the industry’s most advanced property management technology platform, together to assess and complete HVAC work requests from start to finish. Motili automatically schedules, dispatches, manages and invoices job requests. Motili’s predictive analytics improves budgeting accuracy by predicting product life cycle. Learn more about Motili at: http://www.motili.com.

About Motili

Motili’s technology platform allows property managers, owners and investors to easily manage repair and replacement jobs. Motili handles all aspects of the job from scheduling to ordering equipment to invoicing, making Motili the single point of contact for all property maintenance and equipment replacement.

Visit: motili.com to learn more.

Media Contact:

Joanne Hogue

Smart Connections PR

(410) 658-8246

joanne@smartconnectionspr.com

Share article on social media or email:

CARD partners with Lillstreet Art Center to host a sensory friendly workshop


Center for Autism and Related Disorders (CARD), LLC

We have been working on this partnership with Lillstreet Art Center, so we can bring a safe and accessible space to the autism community in Chicago…

WHAT:

Lillstreet Art Center and the Center for Autism and Related Disorders (CARD) are joining forces to host a workshop for children to learn how to create clay candy creatures using pinch pot techniques. Attendees will be able to work with many different stamps, decorations, color, and shapes to personalize their pots in a sensory-friendly environment.

“We have been working on this partnership with Lillstreet Art Center, so we can bring a safe and accessible space to the autism community in Chicago that individuals with ASD and their families can enjoy,” said Erin McNulty, operations manager at the Center for Autism and Related Disorders in Ravenswood.

The workshop is $35 to attend, and all children must be accompanied by an adult. All proceeds from the workshop will benefit Autism Care Today (ACT), a national nonprofit organization founded by CARD Executive Director Dr. Doreen Granpeesheh dedicated to raising awareness and providing services and supports to help children with autism achieve their full potential.

WHEN:

Friday, November 15

6:30 p.m. – 8:30 p.m.

WHERE:

Lillstreet Art Center

4401 N. Ravenswood Ave.

Chicago, IL 60640

WHY:

Autism is a developmental disorder marked by impaired social interaction, limited communication, behavioral challenges, and a limited range of activities and interests. It is estimated that 1 in 40 individuals in the United States are affected by autism. Autism is more common than juvenile diabetes, pediatric AIDS, and pediatric cancer combined. Intensive behavioral intervention has been proven to be effective, yet many individuals go without treatment due to financial constraints. Autism Care Today fills this gap by providing assistance for these children today to ensure they have a better tomorrow.

MORE:

CARD spokesperson is available for interviews. For more information on CARD and ACT, visit their websites at: https://www.centerforautism.com/ and https://www.act-today.org/

Share article on social media or email:

The Esteemed Newport Beach Board Certified Facial Plastic Surgeon Dr. Kevin Sadati Receives the 2019 “Best Cosmetic Surgeon” in both OC Register and OC Weekly Magazines


Facelift_NewportBeach

Best Cosmetic Surgeon

Best Cosmetic Surgeon 5 Years In A Row

Dr. Kevin Sadati is a highly specialized facial plastic surgeon with extraordinary surgical skills. As a trained sculptor and painter, he combines his surgical understanding of the human anatomy with his artistic eye to create harmonious, natural-looking results for each patient. Dr. Sadati has made appearances on TV and media outlets across the nation describing his technique that has been coined the “Natural Lift.” Clients from around the globe travel to see Dr. Sadati for his surgical expertise. He and his surgical team provide the highest standards in patient care from the initial consultation to the conclusion of their care.

In Orange County, there is no shortage of surgeons, each with many years of training and expertise. Dr. Sadati has been picked out by the many, being voted “Best Cosmetic Surgeon” for the 5th year in a row by Orange County Register and recently OC Weekly.

Dr. Sadati stated, “This is a great honor and means, even more, coming from my patients,” he continues, “the entire team at The Gallery of Cosmetic Surgery & Aesthetic Lounge strives to give patients the highest quality of care and superior results. I want to thank not only my patients but also my amazing staff for these awards.”

Dr. Sadati is known for creating natural, beautiful results. He has performed over 3,500 facial rejuvenation procedures using local anesthesia and twilight sedation without the need for general anesthesia. He utilizes his nationally recognized facelift technique called, “Triple-C Plication.” This breakthrough muscle tightening method is used for lower face and neck rejuvenation. His technique was published in the American Journal of Cosmetic Surgery, and he continues to share his expertise at plastic surgery conferences around the nation. He performs all of his surgeries in his state-of-the-art surgical facility to ensure patients have a safe and comfortable environment.

Dr. Sadati makes sure that his practice is patient-centric. During a consultation, he carefully listens to his patients and takes the time to answer their questions, help set realistic goals, and formulate a custom plan for their needs. His patients trust his skill and honesty, which is why he has been voted by Locale Magazine Readers, “Best Plastic Surgeon in Orange County,” and his colleagues have voted him as the, “Best Overall Facial Rejuvenation,” and, “Best Aesthetic Doctor,” at the Aesthetic Show. He has appeared on “The Doctors” TV show by NBC for his outstanding nasal surgical procedures and has swept the nation with his facial rejuvenation techniques.

Along with being a plastic surgeon, Dr. Sadati is an artist. His skills as a painter and sculptor have helped him fine-tune the details of his subject and has allowed for amazing surgical results and aesthetic harmony. His practice is named, “The Gallery of Cosmetic Surgery & Aesthetic Lounge,” as a testament to his love of art and his vision for his practice. Dr. Sadati provides patients with surgical services in his state-of-the-art surgical facility downstairs and has his staff of industry leaders offering non-surgical facial and body rejuvenation in the Aesthetic Lounge, his luxury medical spa on the second floor. Dr. Sadati said, “for our patients who are not candidates for surgery, or those who need to maintain their surgical results, we offer non-surgical facial and body contouring options at the Aesthetic Lounge.” Such options include micro-needling with radiofrequency, fillers, laser resurfacing, and body contouring devices like CoolTone and CoolSculpting.

For more information on Dr. Sadati and his Newport Beach practice at the Gallery of Cosmetic Surgery, visit https://galleryofcosmeticsurgery.com

Gallery of Cosmetic Surgery & Aesthetic Lounge

359 San Miguel Dr #200

Newport Beach, CA 92660

(949) 441-1447

Share article on social media or email:

Torigen Pharmaceuticals Expands Leadership Team with Addition of Two Animal Health Industry Veterans


News Image

Torigen Pharmaceuticals Inc., a commercial-stage companion animal immuno-oncology company, today announced the addition of two deeply experienced animal health executives to the management team to help lead the company’s next phase of growth. Michael Lucroy, DVM, MS, DACVIM (Oncology), joins as vice president of oncology business development, and Blake Hawley, DVM, MBA, has been appointed to the board of directors. Drs. Lucroy and Hawley will harness their deep understanding of the animal health industry and leverage their collective business development experience to help move Torigen forward.

“Drs. Lucroy and Hawley join us at a pivotal time in building out the business as we expand beyond our current offerings to maximizing the impact we have on pets with cancer,” said Ashley Kalinauskas, CEO, Torigen. “During the past six months, Torigen’s U.S. autologous cancer vaccine treatments have increased by an average of more than 40 percent per month, as compared with last year. Our newly formed team is poised to accelerate this growth while fulfilling our mission of making personalized cancer treatment accessible for pet owners and veterinarians.”

Dr. Lucroy joins Torigen from MedVet, where, for the past several years, he was director of the Clinical Studies Center, leading research efforts across the 24-hospital organization. Prior to his role at MedVet, he spent four years in technology acquisitions at Elanco Animal Health and served on the faculties of Oklahoma State University and Purdue University. In assuming this newly created role at Torigen, Dr. Lucroy will be responsible for analyzing current data sets, identifying new therapeutic options and managing national immuno-oncology educational programs.

Dr. Hawley, a leader and innovative entrepreneur in the animal health space, is the founder and CEO of Motega Holdings Inc. (dba Motega Health), a joint venture with Shear-Kershman Laboratories, a 40-year pioneer in the food, pharma and nutraceutical space. Previously, Dr. Hawley served as the president and CEO for an Australian-founded startup, consultant for Jaguar Animal Health and chief commercial officer for Kindred Biosciences. Dr. Hawley has also held various senior management roles at Hill’s Pet Nutrition, a division of Colgate-Palmolive, working across 23 countries and three continents.

“Torigen’s core focus is educating veterinarians on the growing field of immuno-oncology,” said Dr. Lucroy. “The clinical oncology space is seeking alternative treatment options that are safe, effective and affordable. I’m excited to bring new clinical data to the industry while identifying new opportunities to create a commercialization pipeline. As a small, nimble startup, this company can move quickly.”

Cancer is the number-one cause of death in dogs over the age of two. One in four dogs will be impacted by cancer in their lifetimes. Torigen offers exciting potential for pets with cancer through its Autologous Prescription Product, which stimulates an immune response that targets and destroys the cancer cells specific to the patient.

“Torigen is putting together one of the top teams in the animal health industry today,” said Dr. Hawley. “I’m looking forward to contributing to the board of directors and expect it will provide an opportunity for me to help mold and shape this company to become an industry leader in this critically important field of study.”

Experimental autologous cancer vaccines created by Torigen Pharmaceuticals Inc. are regulated by the USDA Center for Veterinary Biologics. Torigen’s Autologous Prescription Product should be used under supervision/prescription of a licensed veterinarian. Safety and efficacy have not been established.

For more information, email info@torigen.com, visit http://www.torigen.com or call 860-519-9956.

About Torigen Pharmaceuticals Inc.

Torigen Pharmaceuticals Inc. is focused on delivering affordable companion animal immuno-oncology products. Its initial patented product line utilizes a portion of the pet patient’s tumor to create a personalized cancer vaccine. With over 10 years of supporting pre-clinical publications, the Torigen team is focused on developing innovative veterinary cancer biologics that allow for the body to recognize foreign tumor-associated antigens and facilitate the reversal of immune senescence. For more information, please visit http://www.torigen.com.

Share article on social media or email:

Mount Sinai Medical-Legal Partnership Expands Legal Services for Neediest Patients


Mount Sinai Medical-Legal Partnership (MSMLP), an organization formed to address the legal needs of Mount Sinai’s neediest patients, unveiled two initiatives that provide free special education law and advocacy assistance to families and patients in need. The announcement was made at an event held Wednesday at Mount Sinai that also honored the work of contributions of Blaine (“Fin”) Fogg, who was a member of the Boards of Trustees of the Mount Sinai Health System.

Cyrus Vance Jr., the Manhattan District Attorney and keynote speaker, commended the efforts to provide legal assistance to patients and families in need. The Manhattan DA’s Criminal Justice Investment Initiative awarded funds to The Legal Aid Society to support two full-time Legal Aid attorneys to provide free legal services for patients at Mount Sinai St. Luke’s Child and Family Services. These attorneys will help patients and their families navigate the special education system.

“The role of law enforcement in the twenty-first century is not merely to arrest and prosecute,” said Mr. Vance. “We can deliver greater public safety and healthier communities if we prevent young people from coming into contact with the justice system in the first place. This is why, through our Criminal Justice Investment Initiative, we have partnered with Mount Sinai, The Legal Aid Society, and other leading organizations to provide the services and support necessary to help disadvantaged children and families succeed. I applaud the Mount Sinai Medical-Legal Partnership’s commitment to assisting New York’s most vulnerable through its new education law and advocacy services.”

The program provides legal services for families, education advocacy for parents and legal guardians, training for social workers and case managers, advocating special education services in schools, and representing youth in suspension hearings. Since 2016, this grant has enabled the Legal Aid Society to help approximately 200 students.

MSMLP also announced the pediatric legal clinic at The Mount Sinai Hospital, a new initiative made possible through philanthropic support that will identify and address the unmet legal needs of low-income pediatric patients and their families. This is a group with substantial unmet needs that can have lifelong consequences.

“We look at the needs of Mount Sinai patients in a holistic manner and believe that if we can work within the legal system to help demolish barriers to education as well as to housing, personal safety, immigration, and access to health care, it will materially improve the health of our patients and the community we serve,” said Barbara Berger Opotowsky, President of MSMLP.

At Wednesday’s event, Mount Sinai paid tribute to Mr. Fogg, a member of Mount Sinai Boards of Trustees for three decades and former chair of the Legal Committee. He was President of The Legal Aid Society of New York until his death this July.

“Mr. Fogg’s commitment to service inspired the formation of the MSMLP. And, I have no doubt that the legacy of that commitment will continue to inspire the lawyers and others who work with the MSMLP for many years to come,” said Beth Essig, Executive Vice President and General Counsel, Mount Sinai Health System.

Recognizing that health care alone is often not enough to make patients well, and that some patients have legal needs that materially affect their health, MSMLP works with legal services providers, law firms, Medicaid managed care companies, and law students to try to meet those needs.

MSMLP, an independent charity, launched in 2016 and works with lawyers from The Legal Aid Society, the LegalHealth and the LGBTQ divisions of the New York Legal Assistance Group, Transcend Legal, and Youth Represent, as well as with dedicated lawyers from the New York City Bar Justice Center and New York City law firms Duane Morris LLP, Hughes Hubbard & Reed LLP, Jenner & Block LLP, Latham & Watkins LLP, Schulte, Roth & Zabel LLP, and Wachtell, Lipton, Rosen & Katz.

In addition to the program at Mount Sinai St. Luke’s Child and Family Services, MSMLP has programs that provide legal help to patients throughout the Mount Sinai Health System including clinical programs such as Mount Sinai Center for Transgender Medicine and Surgery and Palliative Care Services at Mount Sinai.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai’s vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools”, aligned with a U.S. News & World Report’s “Honor Roll” Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of top U.S. hospitals; it is one of the nation’s top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 “Best Hospitals” issue. Mount Sinai’s Kravis Children’s Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology, Mount Sinai St. Lukes and Mount Sinai West are ranked 23rd nationally for Nephrology and 25th for Diabetes/Endocrinology, and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Boekel Scientific has been awarded standards compliance for six blood banking devices from AABB (formerly known as the American Association of Blood Banks)


As a US based manufacturer of medical devices, Boekel Scientific has strategically increased the product line breadth by collaborating with the blood banking industry. – Brian Canna, VP of Marketing

Compliance Notification:

Boekel Scientific has been awarded standards compliance for six blood banking devices from AABB (formerly known as the American Association of Blood Banks). The AABB Standards-Compliant Product Evaluation (SCoPE) Program, an initiative to determine vendor product compliance, was recently launched to evaluate blood banking equipment and supplies. The program was designed to drive consistency and performance in the highly regulated market. The devices are used in blood banks for thawing, storing, and collecting blood and blood products.

Boekel Scientific, a US based manufacturer of medical and laboratory devices, has been awarded standards compliance for the following equipment:

1) Small Platelet Agitator – Part Numbers 301200 / 301200-2

Product Link: https://www.boekelsci.com/small-platelet-incubator-and-agitator.html

2) Small Platelet Incubator – Part Numbers 301550 / 301550-2

Product Link: https://www.boekelsci.com/small-platelet-incubator-and-agitator.html

3) Large Platelet Agitator – Part Numbers 301300 / 301300-2

Product Link: https://www.boekelsci.com/large-platelet-incubator-and-agitator.html

4) Large Platelet Incubator – Part Numbers 301650 / 301650-2

Product Link: https://www.boekelsci.com/large-platelet-incubator-and-agitator.html

5) Plasma Thawer – Part Number 301000

Product Link: https://www.boekelsci.com/plasma-thawer-320.html

6) Blood Collection Mixer / Scale – Part Number 302000

Product Link: https://www.boekelsci.com/touch-screen-blood-collection-mixer.html

Boekel Scientific is an ISO 13495 certified medical device company that specializes in manufacturing blood banking, histology, and microbiology equipment. For more information on these devices please contact Boekel Scientific at (800) 336-6929 or visit our website at https://www.boekelsci.com. For company updates visit the Boekel Scientific LinkedIn page https://www.linkedin.com/company/boekel-scientific. For business development or marketing opportunities please contact Brian Canna, VP of Marketing at Boekel Scientific.

Share article on social media or email:

Bull Springs Skyline Forest Adjacent to Bend, Oregon For Sale


Bull Springs Skyline Forest Map

Once you lay eyes on Bull Springs Skyline Forest, you will agree that it is unquestionably one of the most beautiful blocks of contiguous timberland, not only in Oregon, but, in the entire western United States

Bull Springs Skyline Forest, located just minutes west of Bend is an active privately held tree farm and recreational wilderness covering 32,995+/- contiguous, deeded acres bordering the Deschutes National Forest. The property has significant long-term appreciation potential with opportunity for sustainable timber management, conservation, abundant recreation, in combination with residential and mixed-use development.

“Once you lay eyes on Bull Springs Skyline Forest, you will agree that it is unquestionably one of the most beautiful blocks of contiguous timberland, not only in Oregon, but, in the entire western United States,” said Robb Van Pelt, founding partner of Mason & Morse Ranch Company.

The property has a long history of stewardship dating back to 1916 when Shevlin-Hixon and Brooks-Scanlon opened their logging camps for production. The first Shevlin-Hixon Logging camp was placed at Bull Springs, which was active until 1946. Since that time the forest has been owned by a variety logging companies and portions exchanged with the U.S. Forest Service. In recent years, the property has become of major interest to the surrounding community of Bend, Oregon, conservation groups, land planners and developers who are interested in working together to balance its valuable attributes that ascend across private ownership, forest management, community recreation, government legislation and the westerly urban expansion of Bend, Oregon.

The current zoning is F1 Forest Use. The Deschutes County F1 Forest Use Zone is intended to conserve forestlands with a minimum 240-acre parcel size. Potentially rezoning through Oregon’s Destination Resort designation as a cluster development has become a popular balance between sustainable forest management, recreational open space, and urban expansion.

F1 Forest Use Zone permitted uses include forest operations or forest practices, provisions for wildlife and fishery resources, and other farm uses. Conditional uses permitted include private hunting and fishing, private parks and campgrounds and single-family dwellings.

Bull Springs Skyline Forest combines productive timberlands, conservation and development opportunities together with privacy. The property is one of the largest contiguous parcels in the western united states with stunning views and abundant wildlife just minutes from Bend, Oregon. When you combine the resources of timber, wildlife, water, recreation, conservation and redevelopment potential together with its close proximity to Bend, Oregon, you will find it is truly “One of a Kind.”

“Mason & Morse Ranch Company has been fortunate enough to list and sell some of the finest American farms, ranches and recreational lands across the country,” said Bart Miller, Managing Broker of Mason & Morse Ranch Company. “Bull Springs Skyline Forest is one of America’s legacy properties without question. We want to find the right buyer who recognizes the property’s attributes and values the history of the property in the community.”

About Mason & Morse Ranch Company

A leading provider of land brokerage services across the American west. Services include traditional brokerage and auction. With roots dating back to 1961 in the Roaring Fork Valley near Aspen, Colorado, the company specializes in marketing high-value and large acreage farm, ranch and recreational land properties. Combined, Mason & Morse Ranch Company agents offer clients more than 133 years of experience in real estate land sales. http://www.ranchland.com 1-877-207-9700

Share article on social media or email:

Early Diagnosis, Prompt Treatment Offer Hope for Those With Rare Form of Pulmonary Hypertension Called CTEPH


News Image

As part of Pulmonary Hypertension Awareness Month, on Nov. 13, the Pulmonary Hypertension Association (PHA) sets aside a day to help raise awareness and improve diagnosis of a rare form of pulmonary hypertension (PH) known as chronic thromboembolic pulmonary hypertension (CTEPH). Unlike some forms of PH, CTEPH has several treatment options, including a potentially curative surgery.

CTEPH is a form of pulmonary hypertension caused by old blood clots in the lungs. Some patients with CTEPH also have other changes in their pulmonary arteries that can make them narrower and stiffer. CTEPH stops or slows blood from flowing through the arteries and causes the right side of the heart to pump much harder, which can lead to right-heart failure and death. Symptoms include shortness of breath, fatigue and chest pain. Because these symptoms are similar to other common illnesses such as asthma, people can go months and years without a proper diagnosis.

To accurately diagnose CTEPH, doctors must incorporate a number of tests, including a right heart catheterization to measure blood pressure in the heart and lungs and a ventilation-perfusion (V/Q) scan that highlights how blood circulates through the lungs in order to locate blockages. Although CTEPH is a serious condition, the good news is that advances in treatment offer surgical and treatment options. One of these is a surgery that removes the chronic blood clots from the lungs.

“If left untreated, CTEPH is a deadly condition. Fortunately, it is perhaps the most treatable form of pulmonary hypertension where even a cure is oftentimes possible,” says Gustavo Heresi, M.D., a pulmonologist at Cleveland Clinic.

PHA will host a Facebook Live event at http://www.Facebook.com/PulmonaryHypertensionAssociation on CTEPH Awareness Day:

CTEPH Awareness Day will also feature inspiring stories by individuals with CTEPH through PHA’s “PHaces of Hope” campaign, which involves a community of individuals with PH, caregivers and health care professionals who share what gives them hope while facing this disease.

For resources on CTEPH Awareness Day, visit PHAssociation.org/CTEPHDay. The day’s activities can also be followed on social media using #CTEPHDay.

PHA’s CTEPH Awareness Day campaign is supported by a sponsorship from Bayer.

About the Pulmonary Hypertension Association

Headquartered in Silver Spring, Md., the Pulmonary Hypertension Association (PHA) is the country’s oldest and largest nonprofit patient association dedicated to the pulmonary hypertension (PH) community. Pulmonary hypertension is a rare, chronic and life-threatening disease of the lungs for which no cure currently exists. PHA’s mission is to extend and improve the lives of those affected by PH. To achieve this mission, PHA engages people with PH and their families, caregivers, health care providers, and researchers worldwide who work together to advocate for the PH community, provide support to patients, caregivers and families, offer up-to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit http://www.PHAssociation.org and connect with PHA on Twitter, Instagram and Facebook.

Share article on social media or email: